vs
Side-by-side financial comparison of Bioceres Crop Solutions Corp. (BIOX) and UNIVERSAL DISPLAY CORP \PA\ (OLED). Click either name above to swap in a different company.
UNIVERSAL DISPLAY CORP \PA\ is the larger business by last-quarter revenue ($142.2M vs $77.6M, roughly 1.8× Bioceres Crop Solutions Corp.). UNIVERSAL DISPLAY CORP \PA\ runs the higher net margin — 25.2% vs -9.6%, a 34.8% gap on every dollar of revenue. On growth, UNIVERSAL DISPLAY CORP \PA\ posted the faster year-over-year revenue change (-14.5% vs -16.8%). Over the past eight quarters, UNIVERSAL DISPLAY CORP \PA\'s revenue compounded faster (-5.3% CAGR vs -8.4%).
Bioceres Crop Solutions Corp is a global agricultural technology firm that develops and commercializes sustainable crop solutions including drought-tolerant seed traits, biofertilizers, and biopesticides. It serves farmers across South America, North America, Europe and Asia-Pacific, focusing on raising crop yields while reducing the environmental footprint of agricultural activities.
Universal Display Corporation is a developer and manufacturer of organic light emitting diode (OLED) technologies and materials, and it is a provider of services to the display and lighting industries.
BIOX vs OLED — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $77.6M | $142.2M |
| Net Profit | $-7.4M | $35.9M |
| Gross Margin | 46.8% | 74.6% |
| Operating Margin | 9.3% | 30.1% |
| Net Margin | -9.6% | 25.2% |
| Revenue YoY | -16.8% | -14.5% |
| Net Profit YoY | -20.2% | -44.3% |
| EPS (diluted) | $-0.12 | $0.76 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $142.2M | ||
| Q4 25 | — | $172.9M | ||
| Q3 25 | $77.6M | $139.6M | ||
| Q2 25 | — | $171.8M | ||
| Q1 25 | $60.6M | $166.3M | ||
| Q4 24 | $98.8M | $162.3M | ||
| Q3 24 | $93.3M | $161.6M | ||
| Q2 24 | — | $158.5M |
| Q1 26 | — | $35.9M | ||
| Q4 25 | — | $66.3M | ||
| Q3 25 | $-7.4M | $44.0M | ||
| Q2 25 | — | $67.3M | ||
| Q1 25 | $-1.6M | $64.4M | ||
| Q4 24 | $605.2K | $46.0M | ||
| Q3 24 | $-6.2M | $66.9M | ||
| Q2 24 | — | $52.3M |
| Q1 26 | — | 74.6% | ||
| Q4 25 | — | 76.1% | ||
| Q3 25 | 46.8% | 74.6% | ||
| Q2 25 | — | 77.2% | ||
| Q1 25 | 39.4% | 77.1% | ||
| Q4 24 | 42.0% | 77.0% | ||
| Q3 24 | 40.2% | 77.8% | ||
| Q2 24 | — | 75.8% |
| Q1 26 | — | 30.1% | ||
| Q4 25 | — | 38.9% | ||
| Q3 25 | 9.3% | 30.9% | ||
| Q2 25 | — | 39.9% | ||
| Q1 25 | 1.5% | 41.9% | ||
| Q4 24 | 14.5% | 32.3% | ||
| Q3 24 | 2.5% | 41.5% | ||
| Q2 24 | — | 35.6% |
| Q1 26 | — | 25.2% | ||
| Q4 25 | — | 38.4% | ||
| Q3 25 | -9.6% | 31.5% | ||
| Q2 25 | — | 39.2% | ||
| Q1 25 | -2.6% | 38.8% | ||
| Q4 24 | 0.6% | 28.4% | ||
| Q3 24 | -6.6% | 41.4% | ||
| Q2 24 | — | 33.0% |
| Q1 26 | — | $0.76 | ||
| Q4 25 | — | $1.40 | ||
| Q3 25 | $-0.12 | $0.92 | ||
| Q2 25 | — | $1.41 | ||
| Q1 25 | $-0.02 | $1.35 | ||
| Q4 24 | $0.00 | $0.96 | ||
| Q3 24 | $-0.10 | $1.40 | ||
| Q2 24 | — | $1.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.5M | $516.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $288.3M | — |
| Total Assets | $734.9M | $1.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $516.4M | ||
| Q4 25 | — | $602.4M | ||
| Q3 25 | $15.5M | $603.0M | ||
| Q2 25 | — | $525.2M | ||
| Q1 25 | $38.5M | $571.3M | ||
| Q4 24 | $29.2M | $492.7M | ||
| Q3 24 | $32.3M | $551.6M | ||
| Q2 24 | — | $530.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.8B | ||
| Q3 25 | $288.3M | $1.7B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | $345.0M | $1.7B | ||
| Q4 24 | $346.3M | $1.6B | ||
| Q3 24 | $346.0M | $1.6B | ||
| Q2 24 | — | $1.5B |
| Q1 26 | — | $1.9B | ||
| Q4 25 | — | $2.0B | ||
| Q3 25 | $734.9M | $1.9B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | $798.2M | $1.9B | ||
| Q4 24 | $835.2M | $1.8B | ||
| Q3 24 | $827.3M | $1.8B | ||
| Q2 24 | — | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $108.9M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.03× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $108.9M | ||
| Q4 25 | — | $31.1M | ||
| Q3 25 | $14.4M | $97.2M | ||
| Q2 25 | — | $51.9M | ||
| Q1 25 | $23.3M | $30.6M | ||
| Q4 24 | $-5.4M | $34.7M | ||
| Q3 24 | $5.2M | $79.9M | ||
| Q2 24 | — | $67.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $15.1M | ||
| Q3 25 | — | $84.3M | ||
| Q2 25 | — | $37.5M | ||
| Q1 25 | — | $17.5M | ||
| Q4 24 | — | $22.0M | ||
| Q3 24 | — | $66.2M | ||
| Q2 24 | — | $57.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 8.7% | ||
| Q3 25 | — | 60.4% | ||
| Q2 25 | — | 21.8% | ||
| Q1 25 | — | 10.5% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 41.0% | ||
| Q2 24 | — | 36.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 9.3% | ||
| Q3 25 | — | 9.2% | ||
| Q2 25 | — | 8.4% | ||
| Q1 25 | — | 7.9% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | — | 8.4% | ||
| Q2 24 | — | 5.8% |
| Q1 26 | — | 3.03× | ||
| Q4 25 | — | 0.47× | ||
| Q3 25 | — | 2.21× | ||
| Q2 25 | — | 0.77× | ||
| Q1 25 | — | 0.47× | ||
| Q4 24 | -8.85× | 0.75× | ||
| Q3 24 | — | 1.19× | ||
| Q2 24 | — | 1.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BIOX
Segment breakdown not available.
OLED
| Material sales | $83.7M | 59% |
| Royalty and license fees | $54.2M | 38% |
| Contract research services | $4.3M | 3% |
